Formulary
Nivolumab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Nivolumab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Nivolumab [Specialist drug]: Indications, Dosing, Side Effects and Interactions
Nivolumab [Specialist drug] clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Melanoma,Renal cell carcinoma,Non-small cell lung cancer,Malignant pleural mesothelioma,Urothelial carcinoma,Squamous cell cancer of the head and neck,Classical Hodgkin lymphoma,Gastrointestinal cancer**
- **Adult** (By Intravenous Infusion): Specialist drug - access specialist resources for dosing information.
Side effects
For nivolumab [Specialist drug] Common or very common Abdominal pain; alopecia; anaemia; appetite decreased; arrhythmias; arthralgia; arthritis; chest pain; constipation; cough; cytokine release syndrome; decreased leucocytes; dehydration; diarrhoea; dizziness; dry eye; dry mouth; dyspnoea; electrolyte imbalance; fatigue; fever; gastrointestinal disorders; haemolytic anaemia; headache; hyperglycaemia; hypersensitivity; hypertension; hyperthyroidism; hypoalbuminaemia; hypoglycaemia; hypothyroidism; increased risk of infection; inflammation; infusion related reaction; interstitial lung disease; muscle complaints; musculoskeletal discomfort; nausea; nerve disorders; neutropenia; oedema; pain; renal impairment; respiratory disorders; skin reactions; stomatitis; thrombocytopenia; thyroiditis; vision blurred; vomiting; weight decreased Uncommon Adrenal hypofunction; cardiac inflammation; connective tissue disorders; diabetes mellitus; eosinophilia; eye inflammation; hepatic disorders; hypophysitis; hypopituitarism; metabolic acidosis; pancreatitis; paresis; pericardial disorders; sarcoidosis Rare or very rare Cystitis; demyelination; diabetic ketoacidosis; histiocytic necrotising lymphadenitis; hypoparathyroidism; meningitis aseptic; myopathy; nephritis; neuromuscular dysfunction; severe cutaneous adverse reactions (SCARs); vasculitis Frequency not known Cytomegalovirus infection reactivation; haemophagocytic lymphohistiocytosis; solid organ transplant rejection; thyroid disorder; tumour lysis syndrome Side-effects, further information Immune-related reactions Manufacturer advises that most immune-related adverse reactions improved or resolved with appropriate management, including initiation of corticosteroids and treatment modifications. Infusion-related reactions Manufacturer advises that patients with mild or moderate infusion reactions can continue treatment with close monitoring and use of pre-medication according to local guidelines; discontinue treatment if severe infusion reactions occur.
Medicinal forms
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Nivolumab [Specialist drug] in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

